Výsledky vyhledávání

Evaluation of the Tinetti score and fall risk assessment via accelerometry-based movement analysis

Autor: Giovanna Rizzo, Md. Aktaruzzaman, Claudio L. Lafortuna, Maurizio Ferrarin, Roberto Sassi, G. Bovi, Massimo W. Rivolta, Andrea Caspani, Daniela R. Bonardi

Publikováno v: Artificial intelligence in medicine
95 (2018): 38–47. doi:10.1016/j.artmed.2018.08.005
info:cnr-pdr/source/autori:Massimo W. Rivolta a, Md Aktaruzzamana b, Giovanna Rizzo c, Claudio L. Lafortuna c, Maurizio Ferrarin d, Gabriele Bovi d, Daniela R. Bonardi e, Andrea Caspani f, Roberto Sassi a/titolo:Evaluation of the Tinetti score and fall risk assessment via accelerometry-based movement analysis/doi:10.1016%2Fj.artmed.2018.08.005/rivista:Artificial intelligence in medicine (Print)/anno:2018/pagina_da:38/pagina_a:47/intervallo_pagine:38–47/volume:95

Gait and balance disorders are among the main predisposing factors of falls in elderly. Clinical scales are widely employed to assess the risk of falling, but they require trained personnel. We investigate the use of objective measures obtained from

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9a7bd0291fc8d9024e8a3154b4b74c67
https://pubmed.ncbi.nlm.nih.gov/30195985

Zobrazit plný text záznamu

Short duration treatment in genotype 1 chronic hepatitis C patients with rapid virologic response to pegylated interferon plus ribavirin

Autor: Rinaldo Pellicano, Aldo Manca, Alessia Ciancio, Marco Tabone, R. Bonardi, Mario Rizzetto

Publikováno v: Biomedicine & Pharmacotherapy. 65:303-306

Background In patients with chronic hepatitis C, rapid HCV-RNA clearance under treatment might allow shorter treatment duration without modifying the sustained virological response (SVR) rate. This study evaluated the impact of rapid virological resp

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4443f115ff0e4f7363db3609244d33c0
https://doi.org/10.1016/j.biopha.2011.03.004

Zobrazit plný text záznamu

Automatic vs. clinical assessment of fall risk in older individuals: A proof of concept

Autor: Massimo W. Rivolta, Roberto Sassi, Giovanna Rizzo, Aktaruzzaman, G. Bovi, Maurizio Ferrarin, Daniela R. Bonardi, Claudio L. Lafortuna

Publikováno v: EMBC
Conference proceedings (IEEE Eng. Med. Biol. Soc., Conf.) 2015-November (2015): 6935–6938. doi:10.1109/EMBC.2015.7319987
info:cnr-pdr/source/autori:Rivolta, Massimo W.; Aktaruzzaman, Md; Rizzo, Giovanna; Lafortuna, Claudio L.; Ferrarin, Maurizio; Bovi, Gabriele; Bonardi, Daniela R.; Sassi, Roberto/titolo:Automatic vs. clinical assessment of fall risk in older individuals: A proof of concept/doi:10.1109%2FEMBC.2015.7319987/rivista:Conference proceedings (IEEE Eng. Med. Biol. Soc., Conf.)/anno:2015/pagina_da:6935/pagina_a:6938/intervallo_pagine:6935–6938/volume:2015-November

Falling in elderly is a worldwide major problem because it can lead to severe injuries, and even sudden death. Fall risk prediction would provide rapid intervention, as well as reducing the over burden of healthcare systems. Such prediction is curren

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3a08b0e4bf08f7c8985f48c48c3c7893
https://doi.org/10.1109/embc.2015.7319987

Zobrazit plný text záznamu

Interferon and amantadine in combination as initial treatment for chronic hepatitis C patients

Autor: Salvatore Cusumano, Laura Sidoli, Aldo Manca, Franco Chieppa, Marco Tabone, Benedetto Delmastro, Alberto Biglino, Franco Brunello, Giuseppe Cariti, R. Bonardi, Guido Calleri, Mario Rizzetto, Angelo Pera, Cristiana Laudi, Patrizia Della Monica, Massimo Andreoni

Publikováno v: Journal of Hepatology. 35:517-521

Background/Aims : To evaluate the efficacy and tolerance of amantadine in combination with interferon in the treatment of chronic hepatitis C. Methods : Multi-centre trial including 180 chronic hepatitis C patients without cirrhosis, randomly enrolle

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::f1e06364e48a7fb23d96621c5887ab0d
https://doi.org/10.1016/s0168-8278(01)00166-0

Zobrazit plný text záznamu

Rationale for randomised trials of prostate cancer screening

Autor: Marshfield D. Reding, Detroit R. Demers, Helsinki A. Auvinen, Rotterdam R. Kranse, Alabama A. Oberman, Rotterdam P. Beensterboer, Florence R. Bonardi, Cardiff A. Turkes, Rotterdam F.H. Schröder, Bethesda J. Gohagan, Bethesda N. Simpson, Rotterdam M.A. Dijk, Pittsburgh J.L. Weissfeld, Bethesda P.C. Prorok, Rotterdam J.W.B.W. Rietbergen, Goteborg J. Hugosson, Helsinki L. Teppo, Goteburg G. Aus, Washington E.P. Gellman, Toronto A.B. Miller, Tampere M. Hakama, Quebec B. Candas, Minneapolis J. Mandel, Florence S. Ciatto, Brussels B. Stadaert, Madrid A.B. Sanchez, Madrid A. Paez, St. Louis G.L. Andriole, Lisbon E.C. da Silva, Rotterdam W.I. Kirkels, Antwerp V. Nelen, Rotterdam H.J. de Koning, Lisbon F. Figueiredo, Salt Lake City S. Buys, Rotterdam B.G. Blijenberg, Leeds P.H. Smith, Lund H. Lilja, Antwerp L. Denis, Denver E.D. Crawford, Helsinki U.H. Stenman, Helsinki L. Määttänen, Rotterdam Th.H. van der Kwast, Lisbon H. Monteiro, Antwerp D.B. Rose

Publikováno v: European Journal of Cancer. 35:262-271

Screening for prostate cancer has been advocated by a number of organisations largely because there is good evidence that administration of the test for prostate specific antigen (PSA) results in the detection of cancers at an early stage. However, t

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::ae71f5dd6a71eb361d184e57a8ddf452
https://doi.org/10.1016/s0959-8049(98)00379-7

Zobrazit plný text záznamu

90th Annual Convention Poster Presentations and Abstracts

Autor: C. N. Ellis, D. J. Coyle, H. W. Boggs, G. W. Slagle, P. A. Cole, S. Kuramoto, O. Ihara, T. Oohara, J. Nichols, F. Opelka, J. B. Gathright, J. B. Green, J. B. Poulard, A. Ott, S. Bank, I. B. Margolis, A. Meagher, M. Stuart, J. A. Heine, D. A. Rothenberger, F. D. Nemer, C. E. Christenson, R. C. Saad, J. M. Church, V. W. Fazio, I. C. Lavery, J. R. Oakley, J. W. Milsom, T. K. Schroeder, L. Påhlman, G. Frykholm, B. Glimelius, H. Kashtan, M. Papa, B. Wilson, H. Stern, R. Zelnick, P. Haas, M. Ajlouni, T. Fox, E. Szilagy, B. J. Cummings, J. W. Fleshman, Z. Dreznick, R. D. Fry, I. J. Kodner, R. E. Perry, J. H. Pemberton, W. L. Litchy, A. Ferrara, K. E. Levin, R. B. Hanson, R. L. Cali, G. J. Blatchford, A. G. Thorson, M. A. Christenson, R. M. Pitsch, L. L. Jensen, A. C. Lowry, M. R. B. Keighley, M. Oya, J. Oritz, M. Pinho, J. Asperer, G. Chattaphaday, C. Baeten, J. Konsten, F. Spaans, P. Soeters, A. Habets, W. R. Schouten, J. G. H. Ruseler van Embden, J. J. A. Auwerda, P. M. Sagar, P. Goodwin, P. J. Holdsworth, D. Johnston, C. A. Bundy, D. M. Jacobs, M. P. Bubrick, H. Kashiwagi, F. Konishi, K. Kanazawa, D. O. Woodland, T. J. Saclarides, M. S. Bapna, Y. Kubota, K. Sunouchi, M. Ono, T. Muto, T. Masaki, K. Suzuki, M. Adachi, W. D. Wong, S. M. Goldberg, S. D. Wexner, N. Daniel, D. G. Jagelman, J. Christiansen, O. Rasmussen, B. -W. Zhu, J. G. Williams, J. L. Schottler, S. Heyman, F. Marchetti, A. E. Timmcke, T. C. Hicks, J. E. Ray, M. A. Bernstein, R. D. Madoff, P. F. Caushaj, R. J. Zarbo, C. K. Ma, H. Shida, T. Yamamoto, T. Machida, T. Imanari, J. Y. Wang, Y. T. You, R. P. Tang, J. S. Chen, C. R. Chang-Chien, K. Sugihara, K. Hojo, Y. Moriya, H. Hasegawa, B. Krueger, W. Warren, L. P. Faber, M. E. Abel, Y. S. Y. Chiu, T. R. Russell, P. A. Volpe, R. C. Frazee, J. Roberts, S. Symmonds, S. Snyder, J. Hendricks, R. Smith, N. Merchant, H. Hashmi, T. Scalea, R. Whelan, W. E. Longo, B. J. Gusberg, G. H. Ballantyne, T. Davidson, T. G. Allen-Mersh, B. Gazzard, A. J. G. Miles, C. Wastell, M. Viponde, A. Stotter, R. F. Miller, N. Fieldman, W. W. Slack, J. Tjandra, P. E. Savoca, J. T. Flannery, I. M. Modlin, K. Tsukada, K. Tazawa, E. C. Lavery, G. R. Voeller, G. Bunch, L. G. Britt, J. A. Reis Neto, F. A. Quilici, F. Cordeiro, J. A. Reis, J. B. Wojcik, S. R. Banerjee, D. L. Walters, D. A. Cherry, R. Bleday, J. P. Pena, J. G. Buls, R. Pascual, G. Tripodi, A. Padmanabhan, W. R. Schouter, J. D. Blankensteijn, S. Moenning, P. Huber, C. Simonton, C. Odom, E. Kaplan, S. Nightengale, P. C. Shah, H. F. Hashami, P. Kottmeier, F. Velcek, D. Klotz, R. L. Whelan, M. E. Sher, J. J. Bauer, I. Gelernt, D. P. Launer, A. Gerber, J. J. Nogueras, C. O. Finne, N. Sohn, M. A. Weinstein, R. N. Lugo, M. M. Eisenberg, J. Tsao, S. Galandiuk, W. B. Tuckson, S. Strong, J. R. Oakey, W. L. Ambroze, R. R. Dozois, H. A. Carpenter, A. H. Kartheuser, N. F. LaRusso, R. H. Wiesner, D. M. Ilstrup, C. D. Schleck, W. Ambroze, R. Beart, R. Dozois, B. Wolff, J. Pemberton, K. Kelly, R. Devine, S. Nivatvongs, P. Metzger, S. F. Phillips, A. R. Zinmeister, M. E. Pezim, P. Vignati, J. Cohen, T. J. Stahl, P. L. Roberts, D. J. Schoetz, J. J. Murray, J. A. Coller, M. C. Veidenheimer, Y. Yamazaki, M. B. Ribeiro, D. Sachar, T. M. Heimann, A. H. Aufses, A. J. Greenstein, S. J. Stryker, D. Green, R. S. McLeod, Z. Cohen, J. Cullen, G. R. Greenberg, C. S. Ho, R. Reznick, B. G. Wolff, J. Cangemi, P. Carryer, K. N. Jeejeebhoy, R. MacCarty, L. Weilland, A. J. Senagore, J. M. MacKeigan, J. Guillem, D. P. Ondrula, M. L. Prasad, R. L. Nelson, H. Abcarian, R. J. Coughlin, M. L. Corman, E. D. Prager, D. I. Borison, A. D. Bloom, T. J. Pritchard, E. McGannon, M. V. Sivak, R. van Stolk, S. Hull-Boiner, J. W. Milson, M. Sullivan, G. O. Rosato, J. M. Jorge, P. Durdey, M. J. Kennedy, M. Oster, J. Murray, W. C. Cirocco, L. C. Rusin, A. C. Brown, J. C. Reilly, P. Cataldo, M. A. Luchtefeld, W. P. Mazier, A. F. Wolkomir, F. Ruiz-Moreno, R. Alvarado-Cerna, U. Rodriguez, J. Amaro, B. A. Kerner, G. C. Oliver, T. E. Eisenstat, R. J. Rubin, E. P. Salvati, J. M. Dominguez, J. S. Coon, R. S. Weinstein, M. Kameyama, I. Fukuda, S. Imaoka, T. Iwanga, S. Kyzer, B. Mitmaker, P. H. Gordon, E. Wang, R. H. Grace, P. Gibbons, K. M. W. Scott, A. Berger, H. J. Mischinger, K. Arian-Schad, M. Davis, D. Miller, L. P. Fielding, L. R. Begin, A. M. Bell, A. Shafik, K. Abdel-Moneim, A. Khalid, R. M. Devine, R. W. Beart, L. J. Melton, S. S. Ngoi, J. Chia, P. Goh, E. Sim, P. Godwin, P. Quirke, R. C. Barrett, W. A. Koltun, R. J. Smith, D. Loehner, P. Roberts, M. Veidenheimer, D. Schoetz, G. Chattopadhyay, D. Kumar, K. Hosie, W. Kmiot, A. Mostaf, N. Tulley, I. Harding, R. E. Falcone, S. Wanamaker, S. A. Santanello, L. C. Carey, D. E. Rivera, P. Durdley, P. T. Gross, J. C. Sarles, A. Arnaud, I. Sielezneff, P. Orsoni, A. Joly, B. Limberg, V. M. Stolfi, I. Lavery, J. Oakley, J. Church, V. Fazio, H. J. Asbun, H. Castellanos, J. Asbun, E. R. Franko, R. R. Ivatury, D. Schwalb, R. Saad, T. Schroeder, A. J. Dziki, M. D. Duncan, J. W. Harmon, N. Saini, R. A. Malthaner, M. T. Fernicola, F. Z. Hakki, K. S. Trad, R. M. Ugarte, P. Ryan, H. R. Chang, B. Chavoshan, G. Barsoum, R. Bonardi, A. Scaramelo, A. Possebon, C. Peres, C. Röhrig, A. M. Kappas, J. Ortiz, H. A. Fan, J. Milsom, P. Lechner, P. Lind, H. Cesnik, K. S. Venkatesh, D. M. Larson, D. N. Morrison, P. J. Ramanujam, M. Rubbini, F. Mascoli, C. Mari, V. Bresadola, I. Donini

Publikováno v: Diseases of the Colon & Rectum. 34:1-40

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::dda8bffc758c5d9d75ca999336fb624f
https://doi.org/10.1007/bf02050606

Zobrazit plný text záznamu

Antiglycan antibodies as serological markers in the differential diagnosis of inflammatory bowel disease

Autor: C Sguazzini, Rinaldo Pellicano, Roberto Pagni, Giulio Mengozzi, D Simondi, Mario Rizzetto, Roberta Patrizia Ghignone, Sharmila Fagoonee, Silvia Betteto, R. Bonardi, Marco Astegiano

Publikováno v: Inflammatory bowel diseases 14 (2008): 645–651. doi:10.1002/ibd.20368
info:cnr-pdr/source/autori:Simondi, Daniele; Mengozzi, Giulio; Betteto, Silvia; Bonardi, Renato; Ghignone, Roberta Patrizia; Fagoonee, Sharmila; Pellicano, Rinaldo; Sguazzini, Carlo; Pagni, Roberto; Rizzetto, Mario; Astegiano, Marco/titolo:Antiglycan antibodies as serological markers in the differential diagnosis of inflammatory bowel disease/doi:10.1002%2Fibd.20368/rivista:Inflammatory bowel diseases/anno:2008/pagina_da:645/pagina_a:651/intervallo_pagine:645–651/volume:14

Background: The objective of the study was to evaluate the diagnostic accuracy of recently developed antiglycan serological tests in clinical practice for the diagnosis of Crohn's disease. Methods: This study was a cohort analysis of both clinical an

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::676489c9a5d5dfc43eba3e7cec78a430
https://hdl.handle.net/2318/1890161

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání